Rainbow Childrens MedicareQ2 FY24

Rainbow Childrens Medicare Q2 FY24 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹1,270.4P/E: 44.0Market Cap: ₹12.9K CrSector: Healthcare Services

Management growth scorecard

Revenue

Category 3

Margin

Category 3

Fundraise

N/A

Order

N/A

Capex

Yes

1 of 3 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

Category 3
  • Expansion plans include adding 270 new beds across Hyderabad, Bengaluru, and Chennai in H2 FY24, strengthening the Hub and Spoke model.
  • New hospitals are expected to mature over 4-5 years, reaching occupancy levels of around 50-55%, driving growth in ARPOB, revenue, and EBITDA in coming quarters.
  • Revenue for Q2 FY24 showed 6.3% growth year-on-year; H1 revenue grew 12.7% compared to last year.
  • Patient volumes saw a minor decline (2% outpatient, 1% inpatient) due to seasonal and environmental factors; deliveries grew by 4%.
  • Management targets blended occupancy around 50% including new hospitals by year-end.
  • Case mix improvements and price escalations expected to sustain ARPOB growth at 5-6% annually.
  • International business is growing, now constituting about 4% of revenue, with potential to contribute more in future.
  • The company expects operating leverage and higher occupancies as key drivers for future revenue and margin expansion.

See what Rainbow Childrens Medicare management said on margin guidance — free account, 30 seconds.

Fundraise plans

  • The company currently has a robust balance sheet with a net cash position of Rs. 472 crores as of September 30, 2023.
  • They plan to fund ongoing and planned capital expenditures entirely through internal accruals without any need for debt financing.
  • There is no mention of any current or future plans for fundraising through debt or equity in the transcript.
  • The company is confident of completing all planned capital expenditure via internal funds and cash flows.

See what Rainbow Childrens Medicare management said on order book — free account, 30 seconds.

Capex plans

Yes
  • The company has a robust capital expenditure plan supported by a strong balance sheet with a net cash position of Rs. 472 crores as of September 30, 2023.
  • Approximately Rs. 55 crores was invested in capital expenditures during the recent quarter.
  • Significant expansion is planned in H2 FY24 with the addition of 270 beds via three new hospitals in Hyderabad, Bengaluru, and Chennai to strengthen the Hub and Spoke model.
  • New projects include a 60-bed hospital in Central Hyderabad (launch expected November 14), a 50-bed additional block at Hydernagar, Hyderabad (operational by December), and 80-bed spoke hospitals in Anna Nagar, Chennai and Sarjapur, Bangalore (slated for Q4 FY24).
  • Future expansions include a 60-bed spoke hospital at Hennur, Bangalore and a 100-bed greenfield spoke hospital at Rajahmundry, Andhra Pradesh, expected to commence in the next financial year.
  • The company plans to complete all capital expenditures through internal accruals without debt financing.

Track Rainbow Childrens Medicare — get its next earnings analysis in your feed

How does Rainbow Childrens Medicare rank vs peers in Healthcare Services?

Pro feature
ThisRainbow Childrens Medicare
Rev 3Mar 3

How does Rainbow Childrens Medicare rank in Healthcare Services?

Compare Rainbow Childrens Medicare against every Healthcare Services company (Q2 FY24) on revenue, margins and earnings-call signals.

View Healthcare Services leaderboard →

Others in Healthcare Services this season

  • Chandan Healthca (Q2 FY27)

    Q2 FY27 operating income: ₹57.94 Cr, up 45.04% YoY from ₹39.95 Cr (Page 8) . Key investor presentation takeaways from Chandan Healthcare Ltd's Q2 FY27 investor

  • Invicta Diagnostic (Q2 FY27)

    Revenue from operations for the half year ended September 30, 2026: ₹379.11 lakhs (Page 4). Key results statement takeaways from Invicta Diagnostic Ltd's Q2 FY2

  • Unihealth Hosp (Q2 FY27)

    1,270 million with a year-on-year (YoY) growth of 6.3% . Key results statement takeaways from Unihealth Hospitals Ltd's Q2 FY27 results statement — and how it r

  • Sangani Hospital (Q2 FY27)

    1008.56 lakhs (~11.8% increase). Key results statement takeaways from Sangani Hospitals Ltd's Q2 FY27 results statement — and how it ranks against sector peers.

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →